scout

Authors

Brian J. Miles, MD
Latest Article

Focal Therapy Evolves Into More Precise Treatment in Prostate Cancer

Historically, the management of localized prostate cancer has centered on removal or ablation of the entire gland with either extirpative surgery or radiation. However, the subsequent unacceptable adverse events profile can be devastating and life altering for many patients.

Brian Larson, BS Pharm, RPh
Latest Article

Is Your Practice Ready for New Rules on Hazardous Drug Management

Among community oncology practices, the US Pharmacopeia Convention’s General Chapter draft guidelines have already raised the bar for hazardous drug management and imposed costs for compliance.

Brian M. Slomovitz, MD, Sylvester Comprehensive Cancer Center, University of Miami Health System
Brian Olsen, MD
Latest Article

Hemophagocytic Lymphohistiocytosis in a Patient With Nodular Lymphocyte–Predominant Hodgkin Lymphoma: A Case Report

This is the first case report of hemophagocytic lymphohistiocytosis complicating a nodular lymphocyte–predominant Hodgkin lymphoma in an adult treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone.

Brian Rini,MD, Cleveland Clinic Lerner College of Medicine
Brian Rini,MD, Cleveland Clinic Main Campus
Brian Van Tine, MD, PhD, Washington University
Brice Labruzzo Mohundro, PharmD
Latest Article

On the Horizon for Multiple Myeloma: Update on Novel Agents, Bone Therapies

A new generation of proteasome inhibitors, immunomodulatory agents, and deacetylase inhibitors are currently being investigated in clinical trials to treat patients with relapsed or refractory multiple myeloma.

Brielle Benyon
Latest Article

Rewriting the Rules for a Better Future of Cancer Care

Confidence, support, and hard work paved the way for an exceptionally successful career for Edward S. Kim, MD, MBA, who has a cemented mission in diversifying clinical trials and improving quality of life.

Brielle Urciuoli
Latest Article

Persistence and the Quest for Innovation Guided a Radiotherapy Pioneer

Herman D. Suit, MD, MSc, PhD, a leader in the field of radiation oncology whose innovations lessened the need for radical surgery and improved outcomes for patients, was honored in the Radiation Oncology category with a 2017 Giants of Cancer Care® award.

Brielle Uricioli
Brigitta Torster
Latest Article

NO-Naproxen May Protect Against Colorectal Cancer

A study presented at the AACR 101st Annual Meeting 2010 by researchers from the Fox Chase Cancer Center, Philadelphia, Pennsylvania, provides further evidence that non-steroidal anti-inflammatory drugs (NSAIDs) are promising chemopreventive agents with activity against colorectal cancer.

Britta Stordal, PhD
Latest Article

Biomarkers in Ovarian Cancer: Early Detection and Chemoresistance

Worldwide, there are ~204,000 new cases of ovarian cancer each year, accounting for 4% of cancers diagnosed in women.

Brittany Lovely, OncLive
Brittany Lovely

Managing Editor, OncLive®
Brittany Lovely is a managing editor for the OncologyLive® print publication and editor of the Miami Breast Cancer Conference® and Chemotherapy Foundation Symposium® dailies. Email: blovely@mjhassoc.com


Latest Article

DLL3-Targeting Agents Are Poised to Fill Unmet Needs in SCLC

Expression of DLL3, an inhibitor ligand of the Notch pathway associated with tumorigenesis, has emerged as a target of interest for drug development.

Broadgreen University Hospital NHS Trust
Bruce Cheson, MD, Georgetown Lombardi Comprehensive Cancer Center
Bruce Cheson, MD, Lombardi Comprehensive Cancer Center
Bruce D. Cheson, MD, FACP, FAAAS, Georgetown University Hospital
Bruce E. Johnson, MD, Dana-Farber Cancer Institute
Bryan A. Mehlhaff, MD, Oregon Urology Institute
By Alicia Bitterice, MSN, RN
Latest Article

Managing Chemotherapy-Induced Peripheral Neuropathy

Chemotherapy-induced peripheral neuropathy is a common side effect in patients with cancer and nurses are essential to helping patients to manage this condition.

By Amy J. Hoffman, MSN, PhD, RN
Latest Article

Making the Move to Exercise

Amy Hoffman, MSN, PhD, RN, from Michigan State University's College of Nursing, offers practical tips to help initiate a regular exercise strategy for cancer patients and survivors.

By Andre Goy, MD
Latest Article

Does Lifestyle Matter to Prevent Cancer or Is It Just All “Bad Luck”?

We now have a better understanding of the sequence of events, particularly regarding the timing of these mutations, their impact, and some of the factors involved that might cause them.

By Andrew J. Bredemeyer, PhD
Latest Article

Clinical Next-Generation Sequencing to Guide Cancer Treatment Decisions

In the past year, clinical laboratories have begun determining the tumor mutational status of multiple genes simultaneously using next-generation sequencing platforms.

By Andrew Smith
Latest Article

Improving Practice Efficiency Through Emerging Technologies

The New Year offers little hope of breakthrough software improvements for medical practices, but experts say oncologists can still make 2015 a time of breakthrough productivity gains.

By Anita T. Shaffer
Latest Article

Moving Beyond Targeted Therapy Stalwarts: Experts Weigh In on Four Tumor Types

OncologyLive asked experts in lymphoma, chronic myeloid leukemia, breast cancer, and non–small cell lung cancer to discuss the impact that the first targeted agents have had on these malignancies and the prospects for new therapeutic approaches.

By Ann Partridge, MD, MPH
Latest Article

Improving Cancer Survivorship: Embedding Tailored, Comprehensive Survivorship Care in the Breast Oncology Clinic

Ann Partridge, MD, MPH, from Dana-Farber Cancer Institute and Sandy Truong, a Harvard Medical School student, discuss the needs of cancer survivors and their efforts to optimize survivorship care.

By Arnold B. Etame, MD, PhD
Latest Article

Neurosurgical Innovations Advance Safe Resection of Difficult Brain Tumors

Arnold B. Etame, MD, PhD, from the Moffitt Cancer Center, describes stereotactic neuronavigation, which may offer more surgical visualization capabilities for the neurosurgeon.

By Arta Monjazeb, MD
Latest Article

Translating Combination Radiotherapy/Immunotherapy From Dogs to Humans With Advanced Melanoma or Sarcoma

Arta Monjazeb, MD, and Michael Kent, DVM, from the UC Davis Comprehensive Cancer Center, describe an early phase trial exploring the potential of translating successful treatment from dogs to humans with advanced melanoma or sarcoma.

By Audrey Andrews
Latest Article

ASH 2010: Data Support Escalated BEACOPP as Superior Method of Tumor Control in Early Unfavorable Hodgkin Lymphoma

In patients with early unfavorable Hodgkin lymphoma, an escalated BEACOPP regimen was superior to standard treatment at improving tumor control, according to final data from the German Hodgkin Study Group HD14 trial.